Cited by 318Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchPharmacological Effects and Toxicity Studies

The DOI matches its Crossref record; 156 of the 157 references it cites were found in a registry or an index.

Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy

Johannessen Landmark, Cecilie·2008·CNS Drugs

DOI 10.2165/00023210-200822010-00003

Open this paper in CoChat — free account

Abstract

Antiepileptic drugs (AEDs) are used extensively to treat multiple non-epilepsy disorders, both in neurology and psychiatry. This article provides a review of the clinical efficacy of AEDs in non-epilepsy disorders based on recently published preclinical and clinical studies, and attempts to relate this efficacy to the mechanism of action of AEDs and pathophysiological processes associated with the disorders. Some newer indications for AEDs have been established, while others are under investigation. The disorders where AEDs have been demonstrated to be of clinical importance include neurological disorders, such as essential tremor, neuropathic pain and migraine, and psychiatric disorders, including anxiety, schizophrenia and bipolar disorder. Many of the AEDs have various targets of action in the synapse and have several proposed relevant mechanisms of action in epilepsy and in other disorders. Pathophysiological processes disturb neuronal excitability by modulating ion channels, receptors and intracellular signalling pathways, and these are targets for the pharmacological action of various AEDs. Attention is focused on the glutamatergic and GABAergic synapses. In psychiatric conditions such as schizophrenia and bipolar disorder, AEDs such as valproate, carbamazepine and lamotrigine appear to have clear roles based on their effect on intracellular pathways. On the other hand, some AEDs, e.g. topiramate, have efficacy for nonpsychiatric disorders including migraine, possibly by enhancing GABAergic and reducing glutamatergic neurotransmission. AEDs that seem to enhance GABAergic neurotransmission, e.g. tiagabine, valproate, gabapentin and possibly levetiracetam, may have a role in treating neurological disorders such as essential tremor, or anxiety disorders. AEDs with effects on voltage-gated sodium or calcium channels may be advantageous in treating neuropathic pain, e.g. gabapentin, pregabalin, carbamazepine, oxcarbazepine, lamotrigine and valproate. Co-morbid conditions associated with epilepsy, such as mood disorders and migraine, may often respond to treatment with AEDs. Other possible disorders where AEDs may be of clinical importance include cancer, HIV infection, drug and alcohol abuse, and also in neuroprotection. A future challenge is to evaluate the second-generation AEDs in non-epilepsy disorders and to design clinical trials to study their effects in such disorders in paediatric patients. Differentiation between the main mechanisms of action of the AEDs needs more consideration in drug selection for tailored treatment of the various non-epilepsy disorders.

Integrity signals

Registry

Crossref · 10.2165/00023210-200822010-00003

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,337
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1430 · Cited by 1,243
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
An astrocytic basis of epilepsy
Tian, G.-F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H. R., et al. (2005) · Nature Medicine · doi:10.1038/nm1277 · Cited by 806
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P. J., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 712
Decreased Glutamic Acid Decarboxylase67 Messenger RNA Expression in a Subset of Prefrontal Cortical γ-Aminobutyric Acid Neurons in Subjects With Schizophrenia
Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.237 · Cited by 697
The mechanisms of action of gabapentin and pregabalin
Sills, G. J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.11.003 · Cited by 672
Basic Pharmacology of Valproate
̈scher, W. L. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00003 · Cited by 667
A common mechanism of action for three mood-stabilizing drugs
Williams, R. S. B., Cheng, L., Mudge, A. W., & Harwood, A. J. (2002) · Nature · doi:10.1038/417292a · Cited by 615
Pharmacology and mechanism of action of pregabalin: The calcium channel α2–δ (alpha2–delta) subunit as a target for antiepileptic drug discovery
Taylor, C. P., Angelotti, T. P., & Fauman, E. B. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 566
Topiramate in Migraine Prevention
Silberstein, S. D. (2004) · Archives of Neurology · doi:10.1001/archneur.61.4.490 · Cited by 533
The role of GABA in anxiety disorders.
Lydiard, R. B. (2003) · PubMed · Cited by 528
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 472
Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites
Poolos, N. P., Migliore, M., & Johnston, D. (2002) · Nature Neuroscience · doi:10.1038/nn891 · Cited by 454
Mechanisms of action of valproate: a commentatory
Johannessen, C. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00013-9 · Cited by 400
Mechanisms of Action of Antiepileptic Drugs
Czapiński, P., Błaszczyk, B., & Czuczwar, S. J. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386962 · Cited by 392
Practice Parameter: Therapies for essential tremor [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology
Zesiewicz, T. A., Elble, R., Louis, E. D., Hauser, R. A., Sullivan, K. L., Dewey, R. B., Ondo, W. G., Gronseth, G. S., & Weiner, W. J. (2005) · Neurology · doi:10.1212/01.wnl.0000163769.28552.cd · Cited by 371
Valproate: Past, Present, and Future
Johannessen, C. U., & Johannessen, S. I. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00249.x · Cited by 363
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
Coyle, J. T., & Duman, R. S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00195-8 · Cited by 360
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
Manji, H. K., Duman, R. S., Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330
Comorbidity of migraine and epilepsy
Ottman, R., & Lipton, R. B. (1994) · Neurology · doi:10.1212/wnl.44.11.2105 · Cited by 305
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.07.010 · Cited by 300
The Role of GABA in the Pathophysiology and Treatment of Anxiety Disorders
Nemeroff, C. B., MD, & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4169 · Cited by 263
Treatment-Resistant Bipolar Depression: A STEP-BD Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation With Lamotrigine, Inositol, or Risperidone
Nierenberg, A. A., Ostacher, M. J., Calabrese, J. R., Ketter, T. A., Marangell, L. B., Miklowitz, D. J., Miyahara, S., Bauer, M. S., Thase, M. E., Wisniewski, S. R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.210 · Cited by 253
Mechanisms of the Antinociceptive Action of Gabapentin
Cheng, J., & Chiou, L. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0050020 · Cited by 250
Antiepileptic drugs: indications other than epilepsy
Spina, E., & Perugi, G. (2004) · Epileptic Disorders · doi:10.1684/j.1950-6945.2004.tb00053.x · Cited by 238
Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate
Kumar, N., Laferrière, A., Yu, J. S. C., Leavitt, A., & Coderre, T. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06625.x · Cited by 231
Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura
Lampl, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063750 · Cited by 217
The New Generation of GABA Enhancers
Czuczwar, S. J., & Patsalos, P. N. (2001) · CNS Drugs · doi:10.2165/00023210-200115050-00001 · Cited by 209
Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1
Hoopes, S. P., Reimherr, F. W., Hedges, D. W., Rosenthal, N. R., Kamin, M., Karim, R., Capece, J. A., & Karvois, D. L. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1109 · Cited by 209
A schizophrenia-related sensorimotor deficit links α3-containing GABA A receptors to a dopamine hyperfunction
Yee, B. K., Keist, R., von Boehmer, L., Studer, R., Benke, D., Hagenbuch, N., Dong, Y., Malenka, R. C., Fritschy, J.-M., Bluethmann, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508752102 · Cited by 201
What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
Schmidt, D., & Elger, C. E. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.07.004 · Cited by 191
Depression and Mania in Patients with Epilepsy
Schmitz, B. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463009.x · Cited by 187
An Introduction to Antiepileptic Drugs
Perucca, E. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463007.x · Cited by 185
Genetic essential tremor in γ-aminobutyric acidA receptor α1 subunit knockout mice
Kralic, J. E., Criswell, H. E., Osterman, J. L., O’Buckley, T. K., Wilkie, M. E., Matthews, D. B., Hamre, K., Breese, G. R., Homanics, G. E., & Morrow, A. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23625 · Cited by 184
Depression in Epilepsy: A Neurobiologic Perspective
Kanner, A. M. (2005) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2005.05106.x · Cited by 178
Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Loiseau, P., & Perucca, E. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00106-7 · Cited by 174
Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders
Ettinger, A. B., Reed, M. L., Goldberg, J. F., & Hirschfeld, R. M. A. (2005) · Neurology · doi:10.1212/01.wnl.0000172917.70752.05 · Cited by 160
Topiramate treatment in bulimia nervosa patients: A randomized, double-blind, placebo-controlled trial
Nickel, C., Tritt, K., Muehlbacher, M., Gil, F. P., Mitterlehner, F. O., Kaplan, P., Lahmann, C., Leiberich, P. K., Krawczyk, J., Kettler, C., et al. (2005) · International Journal of Eating Disorders · doi:10.1002/eat.20202 · Cited by 159
Use of Antiepileptic Drugs for Nonepileptic Conditions: Psychiatric Disorders and Chronic Pain
Ettinger, A. B., & Argoff, C. E. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.10.003 · Cited by 157
Molecular targets versus models for new antiepileptic drug discovery
Rogawski, M. A. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.09.012 · Cited by 152
Mood Stabilizers Target Cellular Plasticity and Resilience Cascades: Implications for the Development of Novel Therapeutics
Bachmann, R. F., Schloesser, R. J., Gould, T. D., & Manji, H. K. (2005) · Molecular Neurobiology · doi:10.1385/mn:32:2:173 · Cited by 151
Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate
Coderre, T. J., Kumar, N., Lefebvre, C. D., & Yu, J. S. C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03263.x · Cited by 148
Epilepsy and migraine
BIGAL, M. E., Lipton, R. B., Cohen, J. S., & Silberstein, S. D. (2003) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2003.07.003 · Cited by 140
Valproate oral loading in the treatment of acute mania.
Keck, P. E., McElroy, S. L., Tuğrul, K., & Bennett, J. A. (1993) · PubMed · Cited by 138
A double-blind placebo-controlled trial of topiramate treatment for essential tremor
Connor, G. S. (2002) · Neurology · doi:10.1212/wnl.59.1.132 · Cited by 134
Search for a common mechanism of mood stabilizers
Harwood, A. J., & Agam, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00187-4 · Cited by 134
Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist
Kaminski, R. M., Banerjee, M., & Rogawski, M. A. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.010 · Cited by 129
Cellular and Molecular Actions of Lamotrigine: Possible Mechanisms of Efficacy in Bipolar Disorder
Xie, X., & Hagan, R. M. (1998) · Neuropsychobiology · doi:10.1159/000026527 · Cited by 128
Valproate decreases inositol biosynthesis
Shaltiel, G., Shamir, A., Shapiro, J., Ding, D., Dalton, E. C., Bialer, M., Harwood, A. J., Belmaker, R. H., Greenberg, M. L., & Agam, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.027 · Cited by 128
Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study
Kochar, D. K., Rawat, N., Agrawal, R. P., Vyas, A., Beniwal, R., Kochar, S. K., & Garg, P. (2003) · QJM · doi:10.1093/qjmed/hch007 · Cited by 127
Intravenous Infusion of Phenytoin Relieves Neuropathic Pain: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study
McCleane, G. J. (1999) · Anesthesia & Analgesia · doi:10.1213/00000539-199910000-00030 · Cited by 126
The History of Valproate in Clinical Neuroscience
Henry, T. R., & Schmahl, C. G. (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7071 · Cited by 124
Safety and efficacy of ?-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction
Brodie, J. D., Figueroa, E., LASKA, E. M., & Dewey, S. L. (2004) · Synapse · doi:10.1002/syn.20097 · Cited by 121
Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis
Dou, H., Birusingh, K., Faraci, J., Gorantla, S., Poluektova, L. Y., Maggirwar, S. B., Dewhurst, S., Gelbard, H. A., & Gendelman, H. E. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09162.2003 · Cited by 120
The Actions of Valproate and Neurosteroids in a Model of Trigeminal Pain
Cutrer, F. M., & Moskowitz, M. A. (1996) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1996.3610579.x · Cited by 118
Pharmacology of Valproate
Owens, M. J., PhD, Nemeroff, A. C. B., O’Reardon, J. P., & PhD (2015) · Psychopharmacology Bulletin · doi:10.64719/pb.7072 · Cited by 117
Potential Mechanisms of Action of Lamotrigine in the Treatment of Bipolar Disorders
Ketter, T. A., Manji, H. K., & Post, R. M. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088915.02635.e8 · Cited by 117
Phenytoin as an Antimanic Anticonvulsant: A Controlled Study
Mishory, A., Yaroslavsky, Y., Bersudsky, Y., & Belmaker, R. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.463 · Cited by 116
New antiepileptic drugs that are second generation to existing antiepileptic drugs
Bialer, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.6.637 · Cited by 114
The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder
Pollack, M. H., Roy‐Byrne, P., Ameringen, M. V., Snyder, H., Brown, C. E., Ondrasik, J., & Rickels, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n1109 · Cited by 112
Clinical pharmacology of vigabatrin.
Schechter, P. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03456.x · Cited by 111
Molecular Pharmacology of Topiramate: Managing Seizures and Preventing Migraine
White, H. S. (2005) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.4501006.x · Cited by 108
Visual Field Defects with Vigabatrin
inen, R. K. L., & Nousiainen, I. (2001) · CNS Drugs · doi:10.2165/00023210-200115030-00005 · Cited by 108
Intravenous Infusion of Phenytoin Relieves Neuropathic Pain: A Randomized, Double-Blinded, Placebo-Controlled, Crossover Study
McCleane, G. J. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199910000-00030 · Cited by 107
Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures
Ueda, Y., Doi, T., Tokumaru, J., & Willmore, L. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(03)00183-9 · Cited by 105
Essential tremor: differential diagnosis and current therapy.
Pahwa, R., & Lyons, K. (2003) · American Journal of Medicine · doi:10.1016/s0002-9343(03)00259-6 · Cited by 104
Multiple Mechanisms Underlying the Neuroprotective Effects of Antiepileptic Drugs Against In Vitro Ischemia
Costa, C., Martella, G., Picconi, B., Prosperetti, C., Pisani, A., Filippo, M. D., Pisani, F., Bernardi, G., & Calabresi, P. (2006) · Stroke · doi:10.1161/01.str.0000217303.22856.38 · Cited by 103
Pharmacotherapy and other treatments for cocaine abuse and dependence
Vocci, F. J., & Elkashef, A. M. (2005) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000165596.98552.02 · Cited by 102
Topiramate Add-On in Treatment-Resistant Schizophrenia
Tiihonen, J., Halonen, P. M., Wahlbeck, K., Repo‐Tiihonen, E., Hyvärinen, S., Eronen, M., Putkonen, H., Takala, P., Mehtonen, O. ‐., Puck, M., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0808 · Cited by 98
Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids
Ahmad, S., Fowler, L. J., & Whitton, P. S. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.02.002 · Cited by 94
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania
Arban, R., Maraia, G., Brackenborough, K. T., Winyard, L. A., Wilson, A. W., Gerrard, P. A., & Large, C. H. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.08.015 · Cited by 92
Action tremor with alternating activity in antagonist muscles
Sabra, A. F., & Hallett, M. (1984) · Neurology · doi:10.1212/wnl.34.2.151 · Cited by 88
The Safety and Early Efficacy of Oral-Loaded Divalproex Versus Standard-Titration Divalproex, Lithium, Olanzapine, and Placebo in the Treatment of Acute Mania Associated With Bipolar Disorder
Hirschfeld, R. M. A., Baker, J. D., Wozniak, P., Tracy, K. A., & Sommerville, K. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0717 · Cited by 87
Antiepileptic drugs in schizophrenia: a review
Hosák, L., & Libiger, J. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00696-x · Cited by 85
Efficacy of Topiramate and Valproate in Chronic Migraine
Bartolini, M., Silvestrini, M., Taffi, R., Lanciotti, C., Luconi, R., Capecci, M., & Provinciali, L. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000192136.46145.44 · Cited by 83
Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats
Shannon, H. E., Eberle, E. L., & Peters, S. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.013 · Cited by 82
An Open Trial of Topiramate in the Treatment of Generalized Social Phobia
Ameringen, M. V., Mancini, C., Pipe, B., Oakman, J. M., & Bennett, M. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1213 · Cited by 80
Neurons Recorded from Pediatric Epilepsy Surgery Patients with Cortical Dysplasia
Mathern, G. W., Cepeda, C., Hurst, R. S., Flores‐Hernández, J., Mendoza, D., & Levine, M. S. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01575.x · Cited by 78
Inositol augmentation of lithium or valproate for bipolar depression
A E, E., Demopulos, C., Yovel, I., Culhane, M., Ogutha, J., Grandin, L. D., Nierenberg, A. A., & Sachs, G. S. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00303.x · Cited by 77
The antiepileptic and anticancer agent, valproic acid, induces P‐glycoprotein in human tumour cell lines and in rat liver
Eyal, S., Lamb, J. G., Smith-Yockman, M., Yagen, B., Fibach, E., Altschuler, Y., White, H. S., & Bialer, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706830 · Cited by 76
Topiramate in Migraine Prevention
Silberstein, S. D. (2005) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2005.4501005.x · Cited by 76
Mood Disorders and Their Treatment in Patients With Epilepsy
Prüter-Schwarte, C., & Norra, C. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.1.20 · Cited by 74
Visual field constriction
Sills, G. J., Patsalos, P. N., Butler, E., Forrest, G., Ratnaraj, N., & Brodie, M. J. (2001) · Neurology · doi:10.1212/wnl.57.2.196 · Cited by 71
Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol
Morita, S., Miwa, H., & Kondo, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.09.004 · Cited by 69
The effect of levetiracetam on essential tremor
Bushara, K. O., Malik, T., & Exconde, R. E. (2005) · Neurology · doi:10.1212/01.wnl.0000154596.21335.2e · Cited by 68
Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain
Winkler, I., Blotnick, S., Shimshoni, J. A., Yagen, B., Devor, M. G., & Bialer, M. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706310 · Cited by 66
Effect of lamotrigine on depressive symptoms in adult patients with epilepsy
Ettinger, A. B., Kustra, R. P., & Hammer, A. E. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.09.008 · Cited by 64
Lamotrigine for schizophrenia
Premkumar, T. S., & Pick, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005962.pub2 · Cited by 59
Lamotrigine for bipolar disorder and comorbid cocaine dependence: A replication and extension study
Brown, E. S., Perantie, D. C., Dhanani, N., Beard, L., Orsulak, P. J., & Rush, A. J. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.001 · Cited by 57
Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptors
Yoshida, S., Okada, M., Zhu, G., & Kaneko, S. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.10.001 · Cited by 55
Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders
Brunello, N., & Tascedda, F. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003419 · Cited by 55
Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease
Greene, J. G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.112599 · Cited by 54
Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis
Ju, S., & Greenberg, M. L. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03641.x · Cited by 52
Epileptogenesis and rational therapeutic strategies
Stefan, H., Lopes, F. H. D. S., Löscher, W., Schmidt, D., Perucca, E., Brodie, M. J., Boon, P., Theodore, W. H., & Moshé, S. L. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00561.x · Cited by 51
Pilot efficacy and tolerability: A randomized, placebo‐controlled trial of levetiracetam for essential tremor
Handforth, A., & Martin, F. C. (2004) · Movement Disorders · doi:10.1002/mds.20147 · Cited by 50
Neurochemical Underpinnings in Bipolar Disorder and Epilepsy
Amann, B. L., & Grunze, H. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463006.x · Cited by 49
Levetiracetam for cerebellar tremor in multiple sclerosis
Striano, P., Coppola, A., Vacca, G., Zara, F., Morra, V. B., Orefice, G., & Striano, S. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0112-4 · Cited by 49
Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives
Eyal, S., Yagen, B., Shimshoni, J. A., & Bialer, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.02.012 · Cited by 49
Antiepileptic Drugs and the Regulation of Mood and Quality of Life (QOL): The Evidence from Epilepsy
Selai, C. E., Bannister, D., & Trimble, M. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463010.x · Cited by 48
Shared Mechanisms and Comorbidities in Neurologic and Psychiatric Disorders
Silberstein, S. D. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.01154-3.x · Cited by 46
Gabapentin can improve postural stability and quality of life in primary orthostatic tremor
Rodrigues, J. P., Edwards, D. J., Walters, S. E., Byrnes, M. L., Thickbroom, G. W., Stell, R., & Mastaglia, F. L. (2005) · Movement Disorders · doi:10.1002/mds.20392 · Cited by 45
A controlled study comparing visual function in patients treated with vigabatrin and tiagabine
Krauss, G. L. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.3.339 · Cited by 45
Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder
Muzina, D. J., Elhaj, O., Gajwani, P., Gao, K., & Calabrese, J. R. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00523.x · Cited by 43
Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
Schwartz, T. L., MD, Beale, A. M., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4191 · Cited by 42
Non-epilepsy uses of antiepilepsy drugs.
Zaremba, P., Białek, M., Błaszczyk, B., Cioczek, P., & Czuczwar, S. J. (2006) · PubMed · Cited by 42
Carbamazepine versus Diphenylhydantoin in the Treatment of Myotonia
Sechi, G., Traccis, S., Durelli, L., Monaco, F., & Mutani, R. (2008) · European Neurology · doi:10.1159/000115546 · Cited by 41
Nonepileptic Uses of Antiepileptic Drugs in Children and Adolescents
Golden, A. S., Haut, S. R., & Moshé, S. L. (2006) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.08.017 · Cited by 41
Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically relevant analogue UCN-01
Yeow, W.-S., Ziauddin, M. F., Maxhimer, J. B., Shamimi-Noori, S. M., Baras, A., Chua, A., Schrump, D. S., & Nguyen, D. M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603132 · Cited by 40
Chronic Valproic Acid Treatment Triggers Increased Neuropeptide Y Expression and Signaling in Rat Nucleus Reticularis Thalami
Brill, J., Lee, M. J., Zhao, S., Fernald, R. D., & Huguenard, J. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.5320-05.2006 · Cited by 39
Pharmacologic treatment considerations in co-occurring bipolar and anxiety disorders.
Keck, P. E., Strawn, J. R., & McElroy, S. L. (2006) · PubMed · Cited by 39
Antiepileptic Drugs in Mood‐Disordered Patients
Gajwani, P., Forsthoff, A., Muzina, D. J., Amann, B. L., Gao, K., Elhaj, O., Calabrese, J. R., & Grunze, H. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.463008.x · Cited by 38
Migraine throughout the life cycle
Landy, S. H. (2004) · Neurology · doi:10.1212/wnl.62.5_suppl_2.s2 · Cited by 37
Astrocytes get in the act in epilepsy
Rogawski, M. A. (2005) · Nature Medicine · doi:10.1038/nm0905-919 · Cited by 37
Nuclear Magnetic Resonance Detection of Increased Cortical GABA in Vigabatrin‐Treated Rats In Vivo
Preece, N. E., Jackson, G. D., Houseman, J., Duncan, J. S., & Williams, S. R. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb02456.x · Cited by 36
The acute effect of valproate on cerebral energy metabolism in mice
Johannessen, C. U., Petersen, D., Fonnum, F., & Hassel, B. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00308-4 · Cited by 36
Genetic mouse models of essential tremor: are they essential?
Jankovic, J. J., & Noebels, J. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24544 · Cited by 36
Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain
Winkler, I., Sobol, E., Yagen, B., Steinman, A., Devor, M. G., & Bialer, M. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.008 · Cited by 35
Lamotrigine for neuropathic pain
Eisenberg, E., Shifrin, A., & Krivoy, N. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.6.729 · Cited by 35
Valproate and the symptomatic treatment of schizophrenia spectrum patients
Winterer, G., & Hermann, W. (2000) · Pharmacopsychiatry · doi:10.1055/s-2000-12981 · Cited by 33
Effects of topiramate in patients with cerebellar tremor
Sechi, G., Agnetti, V., Sulas, F. M., Sau, G. F., Corda, D. G., Pitzolu, M. G., & Rosati, G. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00170-2 · Cited by 31
Convergent Effects of Lithium and Valproate on the Expression of Proteins Associated with Large Dense Core Vesicles in NGF-differentiated PC12 Cells
Cordeiro, M. L., Gundersen, C. B., & Umbach, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300288 · Cited by 31
Effects of gabapentin on spontaneous discharges and subthreshold membrane potential oscillation of type A neurons in injured DRG
Yang, R., Xing, J.-L., Duan, J.-H., & Hu, S.-J. (2005) · Pain · doi:10.1016/j.pain.2005.04.001 · Cited by 30
An Open-Label Pilot Study of Levetiracetam for Essential Tremor
Ondo, W. G., Jiménez, J., Vuong, K. D., & Jankovic, J. J. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200411000-00004 · Cited by 29
Effects of valproic acid on an animal model of tardive dyskinesia
Peixoto, M. F., Abílio, V. C., Silva, R. H., & Frussa‐Filho, R. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00025-1 · Cited by 29
Open-Label Adjunctive Topiramate in the Treatment of Unstable Bipolar Disorder
McIntyre, R. S., Riccardelli, R., Binder, C. E., & Kusumakar, V. (2005) · The Canadian Journal of Psychiatry · doi:10.1177/070674370505000705 · Cited by 29
Altered gene expression in mice treated with the mood stabilizer sodium valproate
Chetcuti, A., Adams, L. J., Mitchell, P. B., & Schofield, P. R. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005717 · Cited by 29
Valproic acid in prophylaxis of refractory migraine
Erdemoğlu, A. K., & Özbakır, Ş. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.102006354.x · Cited by 25
Anticonvulsants in the treatment of bipolar mania
Goodnick, P. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.4.401 · Cited by 25
Oxcarbazepine is effective and safe in the treatment of neuropathic pain: pooled analysis of seven clinical studies
Magenta, P., Arghetti, S., Palma, F. D., Jann, S., Sterlicchio, M., Bianconi, C., Galimberti, V. E., Osio, M., Siciliano, G., Cavallotti, G., et al. (2005) · Neurological Sciences · doi:10.1007/s10072-005-0464-z · Cited by 25
Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics
Bennett, S., & Gronier, B. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.015 · Cited by 24
Centrally mediated antihyperalgesic and antiallodynic effects of zonisamide following partial nerve injury in the mouse
Tanabe, M., Sakaue, A., Takasu, K., Honda, M., & Ono, H. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-0006-5 · Cited by 23
Valproic acid inhibits substance P‐induced activation of protein kinase C epsilon and expression of the substance P receptor
Lieb, K., Treffurth, Y., Hamke, M., Akundi, R. S., Kleinsorgen, M. V., & Fiebich, B. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01802.x · Cited by 22
Felbamate relieves several abnormal pain sensations in rats with an experimental peripheral neuropathy.
Imamura, Y., & Bennett, G. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12033-8 · Cited by 22
Disfluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam
Sechi, G., Cocco, G. A., D'ONOFRIO, M., Deriu, M. G., & Rosati, G. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.08.005 · Cited by 21
Phenytoin: an anti-bipolar anticonvulsant?
Bersudsky, Y. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006140 · Cited by 21
Affective Disorder and Epilepsy Comorbidity: Implications for Development of Treatments, Preventions and Diagnostic Approaches
Jobe, P. C. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500112 · Cited by 21
Mood Disorders and Their Treatment in Patients With Epilepsy
Prueter, C. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.1.20 · Cited by 21
The role of anticonvulsants in preventive migraine therapy
Corbo, J. (2003) · Current Pain and Headache Reports · doi:10.1007/s11916-003-0012-6 · Cited by 19
Oxcarbazepine vs. valproate in the treatment of mood and schizoaffective disorders
Raja, M., & Azzoni, A. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003754 · Cited by 16
PharmGKB Submission Update: IV. PMT Submissions of Genetic Variations in ATP-Binding Cassette Transporters to the PharmGKB Network
Nguyen, T. D., Gow, J. M., Chinn, L. W., Kelly, L., Jeong, H., Huang, C. C., Stryke, D., Kawamoto, M., Johns, S. J., Carlson, E. J., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.1 · Cited by 16
Intravenous Fosphenytoin in Acute Mania
Applebaum, J., Levine, J. S., & Belmaker, R. H. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0408 · Cited by 15
ONO-2506. Ono.
de Paulis, T. (2003) · PubMed · Cited by 14
Bronchial asthma as neurogenic paroxysmal inflammatory disease: A randomized trial with carbamazepine
Lomia, M., Tchelidze, T., & Pruidze, M. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.018 · Cited by 13
Alfuzosin and the venous reflex response: studies in normal subjects.
Sinclair, A., Davies, I. B., & Warrington, S. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05330.x · Cited by 13
Shared Mechanisms of Antidepressant and Antiepileptic Treatments: Drugs and Devices
Jobe, P. C. (2004) · Clinical EEG and Neuroscience · doi:10.1177/155005940403500109 · Cited by 11
Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism?
Gallagher, P., Reid, K. S., & Watson, S. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705006450 · Cited by 7
Posters
Ward Janine, L., Berk, M., Lucas Nellie, C., Macneil Craig, A., Hasty, M. K., Kader Linda, F., Conus, P., Allen, N., Yung, A. R., & McGorry Patrick, D. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00226.x · Cited by 4

Research works printed but not linked: 14

Lydiard, 2003, J Clin Psychiatry, 64, 21
Nemeroff, 2003, Psychopharmacol Bull, 37, 133
Kralic, 2005, J Clin Invest, 115, 584, 10.1172/JCI200523625 · DOI
Chetcuti, 2005, Int J Neuropsychopharmacol, 28, 1
Keck, 2005, JClin Psychiatry, 67, 8
Premkumar, 2006, Cochrane Database Syst Rev, &NA;, CD005962
Drake, 2001, Cephalalgia, 21, 373
Krusz, 2001, Cephalalgia, 21, 373
Keck, 1993, J Clin Psychiatry, 54, 305
Manji, 2001, Psychopharmacol Bull, 35, 5
Owens, 2003, Psychopharmacol Bull, 37, 17
Henry, 2003, Psychopharmacol Bull, 37, 5
Myrick, 2003, Prim Psychiatry, 10, 59
De Paulis, 2003, Curr Opin Invest Drug, 4, 863

Sorted by citations

Consensus Paper: Pathological Role of the Cerebellum in Autism
Fatemi, S. H., Aldinger, K. A., Ashwood, P., Bauman, M. L., Blaha, C. D., Blatt, G. J., Chauhan, A., Chauhan, V., Dager, S. R., Dickson, P. E., et al. (2012) · The Cerebellum · doi:10.1007/s12311-012-0355-9 · Cited by 723
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C. S., Craig, D. S., Gafford, E. F., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 641
Mechanisms of action of currently used antiseizure drugs
Sills, G. J., & Rogawski, M. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107966 · Cited by 529
Antiepileptic drug interactions—Principles and clinical implications
I. Johannessen, S., & Johannessen Landmark, C. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246254 · Cited by 343
Adult Cancer Pain
Swarm, R. A., Abernethy, A. P., Anghelescu, D. L., Benedetti, C., Blinderman, C. D., Boston, B., Cleeland, C. S., Coyle, N., deLeon-Casasola, O. A., Eilers, J., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0076 · Cited by 333

See all 318

Authors: Johannessen Landmark, C.
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2008
Volume: 22
Issue: 1
Pages: 27-47
ISSN: 1172-7047 (ISSN-L)
DOI: 10.2165/00023210-200822010-00003
OpenAlex: W2195324906
Cited by: 316
References: 157
Citations by year: 2026: 5 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 17 · 2018: 10 · 2017: 10 · 2016: 22 · 2015: 15 · 2014: 18 · 2013: 27 · 2012: 28
FWCI: 4.86
Type: journal article
Language: en
Open access: closed
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords: antiepileptic drugs, off-label drug use, essential tremor, neuropathic pain, migraine, anxiety disorders, schizophrenia, bipolar disorder, GABAergic neurotransmission, glutamatergic neurotransmission, ion channels, valproic acid, carbamazepine, lamotrigine, topiramate, gabapentin, pregabalin, tiagabine, mood disorders, neuroprotection, second-generation antiepileptic drugs, drug selection
MeSH terms: Anticonvulsants, Anxiety, Mental Disorders, Bipolar Disorder, Humans, Migraine Disorders, Nervous System Diseases, Pain, Schizophrenia, Essential Tremor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks